Humana Inc. HUM remains well-poised for growth on the back of improved premium revenues, an aging U.S. population, acquisitions and adequate cash generation abilities. A strong 2025 outlook reinforces ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

The 5.1% benchmark increase is the largest in the past decade. The hike reflects more recent data capturing cost growth, ...

Humana shares jumped 11% in extended trading on Monday after the federal government said it would pay Medicare insurers more next year than previously expected. Monitor these key chart levels.

Discover PriceSmart's Q2 2025 earnings highlights: record digital sales, strong membership growth, and strategic expansions combating tariff challenges.